Martha Trela, Timothy Mayleben, Maclyn McCarty, and Gregory Schiffman | GenomeWeb

Martha Trela has joined Affymetrix in a sales and marketing position. She comes to Affymetrix from Applied Biosystems, where she had served as vice president for worldwide marketing programs and communications.


Timothy Mayleben has joined the board of directors of Rubicon Genomics, replacing Richard Sloan, the Ann Arbor, Mich.-based company said last week. Most recently, he was COO and CFO of Esperion Therapeutics, which was recently acquired by Pfizer.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.